Back to Search
CHESDA ENG, M.D.
M.D.
Internal Medicine Physician
NPI: 1871811034Individual
Specialties, Licenses & Credentials
Research & Publications (20)
The formin mDia regulates GSK3beta through novel PKCs to promote microtubule stabilization but not MTOC reorientation in migrating fibroblasts.
PMID 16987962·Mol Biol Cell·2006
7-preclinical
A phase 1/2 clinical trial of enzyme replacement in fabry disease: pharmacokinetic, substrate clearance, and safety studies.
PMID 11179018·Am J Hum Genet·2001
3-trial
Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
PMID 11439963·N Engl J Med·2001
3-trial
Experiences in molecular-based prenatal screening for Ashkenazi Jewish genetic diseases.
PMID 11596990·Adv Genet·2001
6-review
Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer.
PMID 19464823·Int J Radiat Oncol Biol Phys·2010
3-trial
Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.
PMID 19399614·Dig Dis Sci·2010
8-other
Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography.
PMID 19144426·Int J Cardiol·2010
8-other
A twenty-year experience with adenocarcinoma of the anal canal.
PMID 19617747·Dis Colon Rectum·2009
4-observational
Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma.
PMID 19503017·Pharmacogenet Genomics·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 632 BROADWAY PH 12
NEW YORK, NY 10012 - Phone
- (347) 294-3414
Quick Facts
- NPI
- 1871811034
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile